Alarming ingredient found in chewing gum linked to heart damage, kidney disease: 'A human health emergency'
Environmental nonprofit City to Sea is teaming up with plastic-free gum company Nuud to raise awareness about the plastic ingredients found in most chewing gums. Talking Retail highlighted the quest, reporting that the U.K. consumes around 4 billion pieces of plastic gum annually, which it says is equal to about 4 billion plastic straws.
The organization is pushing for the government to ban plastic chewing gum and wants to expose what it calls a misleading labeling of ingredients such as polyethylene, which is commonly used in plastic bags, and butadiene-styrene rubber, which is used in car tires.
"Every chew is like biting into a plastic straw," said City to Sea CEO Jane Martin.
According to Talking Retail, 12 tons of this gum are discarded annually in the U.K., ending up on sidewalks and in landfills and waterways. The publication adds that the country shells out millions of pounds every year to remove gum from pavement.
However, the problem is global in scope. GreenSeas Trust, an organization working to eliminate plastic pollution in seas and coastal areas, estimates that chewing gum contributes more than 110,000 tons of plastic pollution annually. It says that this waste exacerbates our microplastic problem, threatening humans and wildlife.
Exposure to microplastics has been tied to heart damage and kidney disease, among other health problems.
"Plastic pollution isn't just an environmental crisis—it's a human health emergency," Martin said, per Talking Retail.
A number of companies offer plastic-free gum. For instance, Simply Gum, a U.S.-based brand, offers gum made from tree sap.
Do you think America has a plastic waste problem?
Definitely
Only in some areas
Not really
I'm not sure
Click your choice to see results and speak your mind.
Meanwhile, we can all do our part to help with the plastic plague by cutting down on single-use plastics.
The problem may seem overwhelming, but some companies are taking action to help cut down on plastic pollution. For instance, McDonald's U.K. banned all plastic cutlery, and some startups are making recyclable plastic out of more eco-conscious ingredients such as food waste and plant cells.
Join our free newsletter for easy tips to save more and waste less, and don't miss this cool list of easy ways to help yourself while helping the planet.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
NSC Applauds Senate Appropriations Committee Passage of Bill Keeping OSHA, NIOSH Funding Steady
WASHINGTON, Aug. 1, 2025 /PRNewswire/ -- Today, the National Safety Council issued the following statement in response to the U.S. Senate Appropriations Committee's passage of legislation that keeps funding steady for the Occupational Safety and Health Administration (OSHA) and the National Institute for Occupational Safety and Health (NIOSH). The Fiscal Year (FY) 2026 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, which passed out of committee by a vote of 26-3, maintains FY2026 funding for OSHA at the FY2025 level and slightly increases FY2026 funding for NIOSH over the FY2025 level. The bill now moves to the full Senate. "The National Safety Council applauds the Senate Appropriations Committee on its decisive vote to keep funding steady for OSHA and NIOSH," said Lorraine Martin, CEO of NSC. "We urge the House and full Senate to approve these funding levels, which are necessary to keep America safe at work." The committee's report language accompanying the bill shines a spotlight on several safety issues, including opioid use in the workplace and heat-related injuries. In expressing concern over the prevalence of opioid use in the workplace, the committee cited NSC data showing that while 75% of employers reported seeing opioid use impact their workplace, only 17% reported being well-prepared to address it. The committee encourages the Secretary of Labor to issue guidance to employers on providing opioid overdose reversal medication and training in the workplace. Learn more about workplace unintentional overdose deaths here: Uncertainty over NIOSH's budget in particular has swirled for months, with an 80% budget cut proposed in June by the U.S. Department of Health and Human Services. In the report, the committee recognized the vital role NIOSH plays in protecting American workers as "the only Federal agency responsible for conducting research and making recommendations for the prevention of work-related illness and injury" and directed the U.S. Centers for Disease Control and Prevention "to ensure work continues in NIOSH research centers nationwide." About the National Safety CouncilThe National Safety Council is America's leading nonprofit safety advocate – and has been for over 110 years. As a mission-based organization, we work to eliminate the leading causes of preventable death and injury, focusing our efforts on the workplace and roadways. We create a culture of safety to not only keep people safer at work, but also beyond the workplace so they can live their fullest lives. Connect with NSC:Facebook Twitter LinkedIn YouTube Instagram ©2025 National Safety Council View original content to download multimedia: SOURCE National Safety Council
Yahoo
a day ago
- Yahoo
No city is safe for allergy sufferers, study finds
There's no escape from it — pollen is in every U.S. state, ready to torment your nostrils. The seeds rain down from the trees in a strange yellow haze and ascends to the skies from the flowers and grasses. Even if you could easily pack up and move, nowhere is safe to avoid the dreaded, sniffling effects of seasonal allergies. 'It's a little bit like playing Russian Roulette,' Hannah Jaffee, the director of research at the Asthma and Allergy Foundation of America, told The Independent. 'If you already have allergies, you can be exposed to an entirely different set of allergens if you relocate.' 'Worst case scenario: you may live in a place and either not have allergy symptoms or have mild allergy symptoms. Then, you move somewhere else and start developing significant symptoms,' she added. Everyone is going to respond differently to a new location. 'If you already have allergies, you can be exposed to an entirely different set of allergens if you relocate. So, you might be trading some symptoms for others.' 'And then, in some cases, your symptoms might improve by relocating,' Jaffee said. More than 100 million Americans live with various types of allergies and over 81 million have seasonal pollen allergies. Some are genetically predisposed to develop allergies, which can factor into what they're allergic to and potentially how severe their symptoms would be. Many people develop allergies as they age and their immune system weakens. Seasonal allergies, which are also commonly known as 'allergic rhinitis' or hay fever, occur when people are exposed to pollen. The inflammatory response can cause sneezing, congestion, a runny nose, or red, watery, and itchy eyes. For people with asthma, it can lead to an asthma attack. For tens of thousands of people, it may even result in a trip to the emergency room. The severity of allergy symptoms also depends on where you live. There are three main types of pollen, including tree, grass, and weed. This year, the highest tree pollen levels were forecast across a wide swath stretching from the Pacific Northwest to the Southeast. The highest weed pollen levels were expected around the Plains states, the Carolinas, and along the Gulf Coast. The foundation also released what it named the nation's top 10 cities for seasonal allergies, with most located in the South and Southeast. Historically, the worst cities are in those regions, Jaffee noted. 'That's because these are climates that tend to be more humid and warmer, so they kind of favor that growth of pollen and mold,' she explained. Wichita, Kansas, led the rankings as the worst city for allergy sufferers. 'Since allergies are so different for everyone, you can thrive in the Southeast part of the U.S. and not have any allergies or still experience significant allergy symptoms elsewhere,' Jaffee said. 'It's kind of a mixed bag.' So, what do you do if you are moving — or want to? Generally, experts recommend that you visit the location for about two to four weeks ahead of time to get a sense of how your body responds, or to visit during different seasons. Talking to an allergist will also be useful for more personalized recommendations. Still, pollen seasons are getting longer and stronger for everyone. Human-caused climate change is resulting in earlier seasons, as well, with warmer temperature trapping heat around urban areas, increasing air pollution, and stimulating pollen production. The amount of pollen released by trees is higher and the strength of the allergic response to the tree pollen appears to be stronger. 'There's no question [that] as there's global warming, the pollen season is increasing,' Dr, Sanjiv Sur, director and professor of Allergy and Immunology at Baylor College of Medicine, said earlier this year. What may help ease the pain, if only for right now? Dr. Neelu Tummala, a clinical assistant professor of otolaryngology at NYU Langone Health, advises that people time taking medications so they are optimally effective, change clothes and take off shoes after spending time outside, and bathe pets. Jaffee recommends a pollen tracking app, in addition to personalized allergy testing. But, ultimately, there needs to be a wider response. 'Long-term, we should be looking at policy change to reduce the impact of climate change,' said the foundation's chief mission officer Melanie Carver. Solve the daily Crossword
Business Insider
2 days ago
- Business Insider
M&A News: AbbVie Eyes $1B Acquisition of Gilgamesh Therapeutics
U.S.-based AbbVie Inc. (ABBV) is reportedly in discussions to buy clinical-stage biotech company Gilgamesh Pharmaceuticals. According to sources familiar with the matter, the deal could be valued at around $1 billion for Gilgamesh. While talks are ongoing, an official announcement might come in the next few weeks. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. AbbVie develops innovative therapies for complex health conditions. Meanwhile, Gilgamesh is a clinical-stage biotech firm working on treatments for psychiatric conditions such as depression, anxiety, and PTSD. AbbVie Turns to M&A for Future Growth The potential deal would bolster AbbVie's pipeline of potential treatments for psychiatric disorders. Notably, Gilgamesh is developing neuroplastogens, a type of next-generation psychedelic compound. Notably, AbbVie continues expanding into mental health treatments after its blockbuster arthritis drug Humira lost U.S. patent protection in 2023, triggering a sales decline. The company now focuses on expanding its drug portfolio, supported by newer therapies and smart acquisitions. According to Reuters, the company has spent more than $20 billion on acquisitions since 2023 to offset its declining sales. Furthermore, the acquisition buzz comes more than a year after AbbVie and Gilgamesh entered into an option-to-license agreement to develop novel therapies for psychiatric disorders. As part of this partnership, AbbVie and Gilgamesh will jointly research and develop next-generation treatments for psychiatric disorders. Separately, the company will release its second-quarter results for 2025 on Thursday, July 31. Analysts on Wall Street expect AbbVie to post earnings of $2.88 per share in its upcoming quarterly report, up from $2.65 reported in the same period last year. Is AbbVie a Good Stock for 2025? On TipRanks, ABBV stock has a consensus Moderate Buy rating among 15 Wall Street analysts. That rating is based on nine Buys and six Holds assigned in the last three months. The average AbbVie stock price target of $209.33 implies an 11% upside from current levels.
